Last reviewed · How we verify

NCT04917627

To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection Rates

Status unknown Phase 4 Last updated 8 June 2021
What this trial tests

Phase 4 trial testing Vancomycin in Wound Infection in 500 participants. Status unknown.

Timeline
1 May 2021
Primary endpoint
1 May 2022
1 May 2022

Quick facts

Lead sponsorHamad General Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment500
Start date1 May 2021
Primary completion1 May 2022
Estimated completion1 May 2022
Sites1 location across Qatar

Drugs / interventions tested

Conditions studied

Sponsor

Hamad General Hospital

Who can join

18 and older, any sex, with Wound Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgical site infection (SSI) after craniotomy is a major cause of morbidity and mortality besides its major health care cost. In each hospital, all measures are taken to decrease SSI. Despite current prophylactic measures, rates of SSIs have been reported in up to 5% of patients post craniotomy. Intrawound vancomycin powder has been studied extensively in spinal fusion surgeries and been found to reduce rates of surgical site infections (SSIs) significantly. Despite its success in spinal surgeries, topical vancomycin has not been extensively studied with respect to cranial neurosurgery. The use of adjuvant vancomycin powder was associated with a significant reduction in the incidence of postoperative infection as well as infection-related medical costs. These findings suggest that the use of adjuvant vancomycin powder in high-risk patients undergoing spinal fusion is a cost-saving option for preventing postoperative infections, as it can lead to cost-savings of $438,165 per 100 spinal fusions performed. The investigators believe that Topical vancomycin is a safe, effective, and cost-saving measure to prevent SSIs following craniotomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vancomycin

Trials testing the same drug.

Other recruiting trials for Wound Infection

Currently open trials in the same condition.

Other Hamad General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04917627.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing